Higher-Order RNA Structure and Function in the HIV-1 Genome
HIV-1 基因组中的高阶 RNA 结构和功能
基本信息
- 批准号:9064527
- 负责人:
- 金额:$ 1.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-03-04 至 2016-06-24
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAntiviral AgentsBinding SitesBioinformaticsClassificationComplexDataDevelopmentDiseaseDrug resistanceEducational process of instructingEpidemicEthicsEvolutionFacultyGenerationsGenetic CodeGenomeGoalsHIVHIV InfectionsHIV-1Higher Order Chromatin StructureIndiumIndividualInfectionInterventionLeadLeadershipModelingMolecularNucleotidesOutcomePharmaceutical PreparationsPositioning AttributeProteinsPublic HealthRNARNA FoldingRNA SequencesRNA-Binding ProteinsRNA-Protein InteractionReagentResearchResolutionRoleSiteStructural ModelsStructureTechniquesTherapeuticTherapeutic InterventionTrainingTraining ProgramsViralViral PackagingVirionVirus ReplicationWorkbasedrug resistant virusexperiencegag Gene Productsgenetic informationgenome-widegenomic RNAinsightnew therapeutic targetnext generation sequencingnovelnovel therapeutic interventionparticlepublic health relevanceresistant strainsmall molecule therapeuticstherapeutic targettoolviral RNAvirology
项目摘要
DESCRIPTION (provided by applicant): The HIV/AIDS epidemic remains a major global public health challenge. Currently 35 million individuals are infected with HIV, and 3 million new infections occur each year. A key challenge in controlling HIV infection is the evolution of drug-resistant strains. New therapeutic strategies are essential to effectively trump viral evolution an eliminate HIV spread. Current retroviral therapies consist of drug cocktails targeting diverse protein-based functions; however, the viral genomic RNA constitutes an unexplored target for viral intervention. Viral replication depends not only on the genetic code contained in the primary
sequence, but also on the functional roles of complex high-order RNA structures. If RNA structure is to be an effective therapeutic target, accurate, nucleotide-resolution models of higher-order structures in the RNA genome must be developed. The goal of this proposal is to identify functional motifs in the HIV-1 genomic RNA using cutting-edge computational and experimental approaches. Computational strategies will be developed to identify and characterize RNA-protein interactions essential for viral maturation and to model tertiary structure motifs throughout the entire 9,200 nucleotide HIV-1 genome. Ultimately, this research will lead to novel high-throughput structural modeling strategies for identification of novel therapeutic targets within HIV-1 that can be applied to any disease-related RNA. Through this training program, I will gain expertise in structural analysis techniques, next generation sequencing, bioinformatics, and virology. My long-term goal is to become a leader in RNA-based disease research, and this experience will be critical as I work toward this objective.
描述(由申请人提供):艾滋病毒/艾滋病流行病仍然是一个重大的全球公共卫生挑战。目前有3 500万人感染艾滋病毒,每年有300万新感染者。控制艾滋病毒感染的一个关键挑战是耐药性菌株的演变。新的治疗策略对于有效战胜病毒进化和消除艾滋病毒传播至关重要。目前的逆转录病毒疗法由靶向不同蛋白质功能的药物鸡尾酒组成;然而,病毒基因组RNA构成了病毒干预的未开发靶点。病毒的复制不仅依赖于初级细胞中的遗传密码,
序列,但也对复杂的高阶RNA结构的功能作用。如果RNA结构是一个有效的治疗目标,准确的,在RNA基因组中的高阶结构的核苷酸分辨率模型必须开发。该提案的目标是使用尖端的计算和实验方法来识别HIV-1基因组RNA中的功能基序。将开发计算策略来识别和表征病毒成熟所必需的RNA-蛋白质相互作用,并在整个9,200个核苷酸的HIV-1基因组中模拟三级结构基序。最终,这项研究将导致新的高通量结构建模策略,用于识别HIV-1中的新治疗靶点,这些靶点可以应用于任何疾病相关的RNA。通过这个培训项目,我将获得结构分析技术,下一代测序,生物信息学和病毒学方面的专业知识。我的长期目标是成为基于RNA的疾病研究的领导者,这段经历对我实现这一目标至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Colleen Ann Kellenberger其他文献
Colleen Ann Kellenberger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
- 批准号:
23K18186 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
- 批准号:
10560883 - 财政年份:2023
- 资助金额:
$ 1.82万 - 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10730692 - 财政年份:2021
- 资助金额:
$ 1.82万 - 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
- 批准号:
21K06459 - 财政年份:2021
- 资助金额:
$ 1.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
- 批准号:
10189880 - 财政年份:2021
- 资助金额:
$ 1.82万 - 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
- 批准号:
2404261 - 财政年份:2020
- 资助金额:
$ 1.82万 - 项目类别:
Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10222540 - 财政年份:2020
- 资助金额:
$ 1.82万 - 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10669717 - 财政年份:2020
- 资助金额:
$ 1.82万 - 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
- 批准号:
20K10713 - 财政年份:2020
- 资助金额:
$ 1.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
- 批准号:
10174522 - 财政年份:2020
- 资助金额:
$ 1.82万 - 项目类别:














{{item.name}}会员




